Category: 23andMe Research

Whole-Genome Sequencing of Parkinson’s Patients

(Editor's note: Here is a link to Cory's poster presented at ASHG.) Parkinson’s disease (PD) research has long been a priority at 23andMe. Our Parkinson’s research community is one of the largest in the world with over 9,300 patients.  Our research on the disease has been published in peer-reviewed ...

Read more

23andMe Moves into the World of Sequencing

(Editor's note: Here is a link to Eoghan's poster presented at ASHG.) People often use the terms “genotyping” and “sequencing” interchangeably, but they are quite different ways of approaching genetic data. One large difference is the amount of data generated. Genotyping, what 23andMe does, tells you ...

Read more

Investigating the Rare

(Editor's note: Here is a link to Brian's poster presented at ASHG.) Rare events are hard to study, and this is especially true in genetics. Imagine you have a group of four people carrying a mutation and two of them are also afflicted with same medical condition.  Coincidence or correlation? Well, this is ...

Read more

Researcher Investigates His Own Genetic Mutation

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

Few Worries About Genetic Testing

A common refrain for critics of direct to consumer genetic testing is that the tests could cause unnecessary worry. Those critics believe that for some tests the results shouldn’t go directly to a consumer and instead be delivered by a doctor or genetic counselor. We believe that a person shouldn’t have to ...

Read more

23andMe Goes to Washington

As we near our goal of enrolling 10,000 patients in 23andMe’s Parkinson’s research community, we are ever more eager to share what we are doing. Last month our CEO, Anne Wojcicki, along with our Parkinson’s research manager Emily Drabant, went to Washington D.C with two friends of 23andMe — Maryum Ali, a ...

Read more

Using Genetics and Family History for Health

For decades, a patient’s family health history has been a keystone to any wellness plan. A simple record of medical conditions your siblings, your parents, aunts, uncles and grandparents struggled with can help you and your doctor know what to watch for to keep you healthy. Like family health histories, ...

Read more

Novel Genetic Findings for Myeloproliferative Neoplasms

Dave Hinds is a Principal Scientist in Statistical Genetics.  23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these disorders consider them to be blood cancers, though individual prognoses can vary widely — some people ...

Read more

The Genetics of Nearsightedness, Stretch Marks, and Motion Sickness

Amy Kiefer is a Survey Research Manager at 23andMe. She joined the company in 2008. What do nearsightedness, stretch marks, and motion sickness have to do with each other? They don’t appear to be genetically related — at least not according to our in-house statistical geneticists — but all of them are ...

Read more

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research ...

Read more

Return to top